BIOASIS TECHNOLOGIES
Bioasis Technologies Inc. is a biopharmaceutical company developing the xB3 â„¢ platform, a proprietary technology for the delivery of therapeutics across the blood brain barrier and the treatment of CNS disorders in areas of high unmet medical need, including brain cancers and neurodegenerative diseases. The delivery of therapeutics across the blood brain barrier represents the final frontier in treating neurological disorders. The in-house development programs at Bioasis are designed to develop symptomatic and disease-modifying treatments for brain-related diseases and disorders.
BIOASIS TECHNOLOGIES
Industry:
Biotechnology Pharmaceutical
Founded:
2007-01-01
Address:
Richmond, British Columbia, Canada
Country:
Canada
Website Url:
http://www.bioasis.us
Total Employee:
101+
Status:
Active
Contact:
1.203.390.7395
Email Addresses:
[email protected]
Total Funding:
8.85 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Axcella
Axcella is a biotechnology company providing therapeutics development solutions.
Burzynski Research Institute
Burzynski Research Institute (BRI) is a biopharmaceutical company.
Context Therapeutics
Context Therapeutics is a clinical-stage biopharmaceutical company.
Leap Therapeutics
Leap Therapeutics is a clinical-stage biopharmaceutical company.
Current Employees Featured
Founder
Stock Details
Investors List
The Lind Partners
The Lind Partners investment in Post-IPO Debt - Bioasis Technologies
Official Site Inspections
http://www.bioasis.us Semrush global rank: 5.62 M Semrush visits lastest month: 1.5 K
- Host name: 141.193.213.20
- IP address: 141.193.213.20
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
